⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACRV News
Acrivon Therapeutics, Inc. Common Stock
UPDATE -- Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates via Webcast
globenewswire.com
ACRV
Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates
globenewswire.com
ACRV
Acrivon Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights
globenewswire.com
ACRV
Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ACRV